Related Experiment Videos
Management of hyperinsulinism in infancy and childhood
1London Centre for Paediatric Endocrinology and Metabolism, Great Ormond Street Hospital for Children NHS Trust, and the Institute of Child Health, University College London, UK.
Insights
Infantile hyperinsulinism (HI) is a difficult endocrine disorder. Despite advances, neurological outcomes and treatments for HI remain challenging for pediatricians.
Area of Science:
- Pediatric Endocrinology
- Metabolic Disorders
- Neonatal Care
Background:
- Infantile hyperinsulinism (HI) poses significant management challenges in pediatric endocrinology.
- Despite recent understanding, neurological outcomes and treatment options for HI remain suboptimal.
- This review addresses the complexities of managing HI in infants.
Purpose of the Study:
- To provide an updated review on the management of infantile hyperinsulinism (HI).
- To consolidate current knowledge and recommendations based on a consensus workshop.
- To address the persistent challenges in neurological outcomes and treatment efficacy for HI.
Main Methods:
- Literature review focusing on advancements in understanding and managing HI.
- Synthesis of information from a European Network for Research into Hyperinsulinism (ENRHI) Consensus Workshop held in 1999.
- Analysis of contemporary pediatric endocrinology practices for HI.
Main Results:
- Hyperinsulinism in infancy remains a complex pediatric endocrine challenge.
- Neurological outcomes for affected infants are often poor.
- Current treatment strategies for HI are frequently unsatisfactory.
Conclusions:
- Effective management of infantile hyperinsulinism requires ongoing research and consensus.
- Improved therapeutic approaches are needed to enhance neurological outcomes.
- Pediatricians face persistent difficulties in managing this condition effectively.
Abstract:
Hyperinsulinism (HI) in infancy presents a formidable challenge for the paediatrician as it is one of the most difficult problems to manage in contemporary paediatric endocrinology. Although there have been major advances in understanding the condition over the last five years, the neurological outcome remains poor choice, and the choice of treatments continue to be unsatisfactory. This review article updates the management of HI derived from a Consensus Workshop held by the European Network for Research into Hyperinsulinism (ENRHI) in 1999.